Literature DB >> 14602010

Carbocyclic isoadenosine analogues of neplanocin A.

Katherine L Seley1, Sylvester L Mosley, Fanxing Zeng.   

Abstract

[structure: see text] Isoadenosine (IsoA), a structural isomer of adenosine, was shown to possess interesting biological activity but was inherently unstable. In an effort to overcome this, we have designed a series of carbocyclic IsoA analogues, combining the unique connectivity of IsoA with the structural features of some biologically significant Neplanocin A analogues. Their design, synthesis, and structural elucidation is reported.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602010     DOI: 10.1021/ol035696q

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Synthetic strategies toward carbocyclic purine-pyrimidine hybrid nucleosides.

Authors:  Joshua M Sadler; Sylvester L Mosley; Kathleen M Dorgan; Zhaohui Sunny Zhou; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2009-06-23       Impact factor: 3.641

2.  Mechanistic studies in the synthesis of a series of thieno-expanded xanthosine and guanosine nucleosides.

Authors:  Zhibo Zhang; Orrette R Wauchope; Katherine L Seley-Radtke
Journal:  Tetrahedron       Date:  2008-11-24       Impact factor: 2.457

3.  "Reverse" carbocyclic fleximers: synthesis of a new class of adenosine deaminase inhibitors.

Authors:  Sarah C Zimmermann; Joshua M Sadler; Peter I O'Daniel; Nathaniel T Kim; Katherine L Seley-Radtke
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2013       Impact factor: 1.381

4.  Hetero-expanded purine nucleosides. Design, synthesis and preliminary biological activity.

Authors:  Katherine L Seley-Radtke; Zhibo Zhang; Orrette R Wauchope; Sarah C Zimmermann; Alexander Ivanov; Brent Korba
Journal:  Nucleic Acids Symp Ser (Oxf)       Date:  2008

Review 5.  The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold.

Authors:  Katherine L Seley-Radtke; Mary K Yates
Journal:  Antiviral Res       Date:  2018-04-10       Impact factor: 10.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.